Lior H. Katz - Concepedia

Author

Lior H. Katz

Also Known As

Eran Goldin, K Alvarez-Valenzuela, L H Katz, L Katz, L. H. Katz, L. Katz, L.H. Katz, LIOR KATZ, Lior H Katz, Lior H. Katz

183

Publications

5.9K

Citations

H-Index

Concepts

All Affiliations

Sheba Medical Center Tel Aviv University Hadassah Medical Center Hebrew University of Jerusalem Rabin Medical Center

About

Lior H. Katz is an author at Sheba Medical Center specializing in medicine, pathology, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	428
2	Public Health	5	5	99
3	Epidemiology	3	3	60
4	Allergy	1	1	32
5	Cell Biology	1	1	56

Lior H. Katz

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients Erez N. Baruch, Ilan Youngster, Guy Ben‐Betzalel, Science	2020	1.4K
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database Mev Dominguez–Valentin, Julian R. Sampson, Toni T. Seppälä, Genetics in Medicine	2019	615
The immunogenic part of infliximab is the F(ab')2, but measuring antibodies to the intact infliximab molecule is more clinically useful Shomron Ben‐Horin, Miri Yavzori, Lior H. Katz, Gut	2010	204
Doubling the infliximab dose versus halving the infusion intervals in Crohnʼs disease patients with loss of response Lior H. Katz, Javier P. Gisbert, Beth Manoogian, Inflammatory Bowel Diseases	2012	130
Heat Shock Factor 1-dependent extracellular matrix remodeling mediates the transition from chronic intestinal inflammation to colon cancer Oshrat Levi-Galibov, Hagar Lavon, Rina Wassermann-Dozorets, Nature Communications	2020	101
Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database Mev Dominguez–Valentin, Saskia Haupt, Toni T. Seppälä, EClinicalMedicine	2023	91
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt, The Lancet. Gastroenterology & hepatology InflammationAnti-inflammatoryImmunologyGastroenterologyMaintenance Therapy	2021	89
Clinical utility of antihuman lambda chain-based enzyme-linked immunosorbent assay (ELISA) versus double antigen ELISA for the detection of anti-infliximab antibodies Uri Kopylov, Yoav Mazor, Miri Yavzori, Inflammatory Bowel Diseases	2011	85
Adolescent body mass index and risk of colon and rectal cancer in a cohort of 1.79 million Israeli men and women: A population‐based study Zohar Levi, Jeremy D. Kark, Lior H. Katz, Cancer	2017	71
Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report Toni T. Seppälä, Aysel Ahadova, Mev Dominguez–Valentin, Hereditary Cancer in Clinical Practice	2019	61

Page 1